Radioprotectors

Radioprotectors

 

chemical compounds used to protect living organisms—microorganisms, plants, animals, and man—from ionizing radiation. Radioprotectors are introduced into the environment or directly into the organism before or during irradiation. Effective radioprotectors include compounds containing sulfhydryl (thiol) groups (—SH), such as cysteine, mercaptoamines and indolylalkylamines. Radioprotectors generally diminish the consequences of irradiation, that is, its fatal and nonfatal effects, including genetic effects. They also reduce the intracellular or interstitial oxygen pressure and increase the amount of endogenous thiols, which is accompanied by a decrease in the oxidation-reduction potential.

The effectiveness of radioprotectors is expressed by a dose reduction factor, which is equal to the ratio of radiation doses producing identical effects in the presence or absence of radioprotectors. The dose reduction factor depends on the conditions of the irradiation and the physical properties of the radiation: with irradiation during a state of hypoxia, the factor is less than with irradiation in the presence of oxygen. The factor is less during radiation with high linear energy transfer (α particles, neutrons, and heavy ions) than during radiation with low linear energy transfer (X rays and γ rays). The effect of radioprotectors also depends on the properties of the organism. Thus, some radioprotectors may protect microorganisms and cells in a culture and not protect mammals.

REFERENCES

Bacq, Z. M. Khimicheskaia zashchita ot ioniziruiushchei radiatsii. Moscow, 1968. (Translated from English.)
Romantsev, E. F. Radiatsiia i khimicheskaia zashchita [2nd ed.]. Moscow, 1968.
Graevskii, E. Ia. Sui’fgidril’nye gruppy i radiochuvstvitel’nost’. Moscow, 1969.
Sumarukov, G. V. Okislitel’noe ravnovesie i radiochuvstvitel’nost’ organizmov. Moscow, 1970.

V. I. KOROGODIN

References in periodicals archive ?
This increase in the cancer rate demands a need for radioprotectors which can provide protection at different doses of ionizing radiation (IR), can be orally administered with least toxicity at higher doses, readily absorbed, easily available in nature and cost effective.
Considering that RAS can be involved in the pathogenesis of radiation-induced changes, inhibitors of this system have been used in the prevention and/or reduction of the severity of these tecidual damages, acting as radioprotectors.
Radioprotectors and Mitigators of Radiation- induced normal tissue Injury.
Thus radioprotectors are of great importance in clinical radiation therapy (Maurya et al.
In fact, exploitation of the ideal radioprotectors has always been emphasized in the field of radiation while most of the radiation protectants currently being developed have certain shortcomings related to efficacy or toxicity [4,5].
However, the application of antioxidant radioprotectors to human exposures including radiation exposures during diagnosis and treatment has not been extensively studied and established.
Therefore, agents which can protect cellular membranes against IR and ROS/RNS will have potential benefits as radioprotectors, antioxidant and antimutagens (Odin 1997; Stavric 1994).
While its role as a therapy to reduce side effects of radiation on humans is ongoing, recent studies have shown that dietary supplements containing lipoic acid can act as radioprotectors in mice.
It is important to identify new radioprotectors for capillary endothelial cells for use during radiotherapy to minimize normal tissue damage and possibly to increase the deliverable dose.
This database includes reactions of many compounds of industrial and biochemical interest, such as antioxidants, vitamins, dyes, photosensitizers, radiosensitizers, radioprotectors, amino acids, and enzymes; and provides kinetic information on many unstable species of physiological and atmospheric importance.
In vivo and photophysical studies on photooxidative damage to lens protein and their protection by radioprotectors.